CVD outcomes . | 1-year change in physical activity per increase of 100 MET-min/week . | |||||
---|---|---|---|---|---|---|
Change in accelerometery-measured total MVPA . | Change in accelerometry-measured MVPA in bouts ≥10 min . | Change in self-reported measured physical activity . | ||||
Events (N)* . | HR (95% CI)** . | Events (N)* . | HR (95% CI)** . | Events (N)* . | HR (95% CI)** . | |
Primary outcome# | 247 (1,552) | 1.002 (0.992, 1.013) | 247 (1,552) | 1.001 (0.985, 1.017) | 277 (1,817) | 1.004 (0.989, 1.019) |
Secondary outcome 1$ | 174 (1,555) | 0.991 (0.975, 1.007) | 174 (1,555) | 0.989 (0.966, 1.013) | 197 (1,821) | 1.000 (0.981, 1.019) |
Secondary outcome 2 | 318 (1,552) | 0.999 (0.989, 1.009) | 318 (1,552) | 0.997 (0.982, 1.012) | 360 (1,817) | 1.000 (0.987, 1.014) |
Secondary outcome 3& | 375 (1,548) | 0.994 (0.983, 1.004) | 375 (1,548) | 0.990 (0.974, 1.006) | 425 (1,811) | 0.998 (0.986, 1.011) |
4-year change in physical activity per increase of 100 MET-min/week | ||||||
Primary outcome# | 164 (1,610) | 0.973 (0.953, 0.993) | 164 (1,610) | 0.946 (0.909, 0.984) | 173 (1,685) | 1.002 (0.982, 1.022) |
Secondary outcome 1$ | 127 (1,655) | 0.949 (0.923, 0.976) | 127 (1,655) | 0.895 (0.841, 0.953) | 134 (1,730) | 0.985 (0.960, 1.011) |
Secondary outcome 2 | 225 (1,610) | 0.967 (0.950, 0.985) | 225 (1,610) | 0.940 (0.908, 0.973) | 236 (1,685) | 0.989 (0.971, 1.008) |
Secondary outcome 3& | 259 (1,577) | 0.974 (0.958, 0.990) | 259 (1,577) | 0.946 (0.917, 0.976) | 271 (1,650) | 0.993 (0.977, 1.010) |
CVD outcomes . | 1-year change in physical activity per increase of 100 MET-min/week . | |||||
---|---|---|---|---|---|---|
Change in accelerometery-measured total MVPA . | Change in accelerometry-measured MVPA in bouts ≥10 min . | Change in self-reported measured physical activity . | ||||
Events (N)* . | HR (95% CI)** . | Events (N)* . | HR (95% CI)** . | Events (N)* . | HR (95% CI)** . | |
Primary outcome# | 247 (1,552) | 1.002 (0.992, 1.013) | 247 (1,552) | 1.001 (0.985, 1.017) | 277 (1,817) | 1.004 (0.989, 1.019) |
Secondary outcome 1$ | 174 (1,555) | 0.991 (0.975, 1.007) | 174 (1,555) | 0.989 (0.966, 1.013) | 197 (1,821) | 1.000 (0.981, 1.019) |
Secondary outcome 2 | 318 (1,552) | 0.999 (0.989, 1.009) | 318 (1,552) | 0.997 (0.982, 1.012) | 360 (1,817) | 1.000 (0.987, 1.014) |
Secondary outcome 3& | 375 (1,548) | 0.994 (0.983, 1.004) | 375 (1,548) | 0.990 (0.974, 1.006) | 425 (1,811) | 0.998 (0.986, 1.011) |
4-year change in physical activity per increase of 100 MET-min/week | ||||||
Primary outcome# | 164 (1,610) | 0.973 (0.953, 0.993) | 164 (1,610) | 0.946 (0.909, 0.984) | 173 (1,685) | 1.002 (0.982, 1.022) |
Secondary outcome 1$ | 127 (1,655) | 0.949 (0.923, 0.976) | 127 (1,655) | 0.895 (0.841, 0.953) | 134 (1,730) | 0.985 (0.960, 1.011) |
Secondary outcome 2 | 225 (1,610) | 0.967 (0.950, 0.985) | 225 (1,610) | 0.940 (0.908, 0.973) | 236 (1,685) | 0.989 (0.971, 1.008) |
Secondary outcome 3& | 259 (1,577) | 0.974 (0.958, 0.990) | 259 (1,577) | 0.946 (0.917, 0.976) | 271 (1,650) | 0.993 (0.977, 1.010) |
Events for 1-year analyses occurred between year 1 and a maximum of 13.5 years of follow-up; events for 4-year analyses occurred between year 4 and a maximum of 13.5 years of follow-up.
Controlling for treatment group, age, baseline physical activity, sex, baseline history of CVD, duration of diabetes at baseline, using insulin or other diabetes medication, baseline weight, and change in weight.
First occurrence after study enrollment of nonfatal myocardial infarction or stroke, hospitalized angina, or CVD death.
CVD death, nonfatal myocardial infarction, or nonfatal stroke.
All-cause death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina.
All-cause death, nonfatal myocardial infarction, nonfatal stroke, hospitalization for angina; hospitalization for congestive heart failure, coronary artery bypass graph, carotid endarterectomy, or peripheral vascular disease.